Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M93.5Revenue $M33.6Net Margin (%)13.9Z-Score-4.4
Enterprise Value $M45.6EPS $0.3Operating Margin %-11.5F-Score5
P/E(ttm))32.7Cash Flow Per Share $0Pre-tax Margin (%)13.9Higher ROA y-yY
Price/Book2.410-y EBITDA Growth Rate %0Quick Ratio7.5Cash flow > EarningsN
Price/Sales2.85-y EBITDA Growth Rate %0Current Ratio7.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)8.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)12.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M14.7ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ARDM

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARDMJean-Marie Eveillard 2014-06-30 Buy 0.08%$0.185 - $9.52
($3.37)
$ 6.3547%New holding3,854,730
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARDM is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ARDM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
THOMPSON VIRGILDirector 2013-12-13Sell84$6.8-6.62view
Grifols SADirector, 10% Owner 2013-08-27Sell0$0-6.62view
Boxer Capital, LLC10% Owner 2013-05-20Sell0$0-6.62view
DEF Associates Ltd.See footnote below 2012-01-01Sell0$0-6.62view
DEF Associates LPSee Footnote 1 below 2010-12-31Sell0$0-6.62view
First Eagle Value in BiotechnoSee remarks. 2009-02-23Sell0$0-6.62view
First Eagle Value in Biotechno10% Owner 2009-02-23Sell0$0-6.62view
Grimes D JefferyVP Legal Affairs, Secretary 2008-07-01Sell0$0-6.62view
RA Capital Biotech Fund II, L.10% Owner 2007-03-01Sell0$0-6.62view
TANG KEVIN C10% Owner 2007-01-25Sell0$0-6.62view

Press Releases about ARDM :

    Quarterly/Annual Reports about ARDM:

    News about ARDM:

    Articles On GuruFocus.com
    Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 
    Eveillard’s First Eagle Seizes 45% of Pharamaceutical Company, Aradigm Dec 19 2012 

    More From Other Websites
    ARADIGM CORP Financials Mar 24 2015
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of... Mar 20 2015
    ARADIGM CORP Files SEC form 10-K, Annual Report Mar 18 2015
    ARADIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 17 2015
    Aradigm Announces Fourth Quarter 2014 and Full Year Financial Results Mar 17 2015
    Aradigm reports 4Q loss Mar 17 2015
    Aradigm reports 4Q loss Mar 17 2015
    Aradigm Announces Fourth Quarter 2014 and Full Year Financial Results Mar 17 2015
    Aradigm Corporation President & CEO Dr. Igor Gonda, Ph.D. to Be Interviewed Live on iHeart Radio/... Feb 27 2015
    Aradigm Corporation President & CEO Dr. Igor Gonda, Ph.D. to Be Interviewed Live on iHeart Radio/... Feb 27 2015
    Aradigm to Present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2015... Feb 04 2015
    Aradigm Granted Key Composition of Matter Patents for Pulmaquin in Europe and Australia Jan 14 2015
    Aradigm Granted Key Composition of Matter Patents for Pulmaquin in Europe and Australia Jan 14 2015
    Aradigm to Present at Biotech Showcase 2015 on January 14 Jan 08 2015
    Aradigm to Present at Biotech Showcase 2015 on January 14 Jan 08 2015
    Investors' Radars Failed to Catch Aradigm (ARDM), Has Yours? Nov 28 2014
    Aradigm to Present at the Stifel Healthcare Conference 2014 Nov 12 2014
    Aradigm to Present at the Stifel Healthcare Conference 2014 Nov 12 2014
    ARADIGM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 07 2014
    Aradigm Announces Third Quarter 2014 Financial Results Nov 07 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK